SCHEMBL3205424

SCHEMBL3205424

COc1ccc(N(Cc2cnco2)c2cccc(C(=O)OC(C)(C)C)c2)cc1OC(C)C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.37
PDE4B Q07343 1/20 0.35
GPR119 Q8TDV5 1/20 0.34
IMPDH2 P12268 4/20 0.34
SLC7A5 Q01650 1/20 0.33
RXRA P19793 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BUB1 O43683 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
IMPDH1 P20839 1/20 0.32
NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3192278 0.92 AAK1 (0.39) AAK1PDE4BGPR119IMPDH2RXRA
SCHEMBL3199477 0.92 AAK1 (0.33) AAK1PDE4BSLC7A5RXRAMAPT
SCHEMBL3207092 0.89 POLB (0.39) AAK1PDE4BGPR119IMPDH2SLC7A5
SCHEMBL3123133 0.89 SREBF1 (0.37) AAK1PDE4BGPR119IMPDH2KDM4E
SCHEMBL3214257 0.89 RXRA (0.40) AAK1PDE4BIMPDH2RXRARXRB
SCHEMBL3129701 0.87 SREBF1 (0.40) AAK1GPR119IMPDH2ALDH1A1MAPT
SCHEMBL3217020 0.87 SLC7A5 (0.37) PDE4BSLC7A5RXRAKDM4EALDH1A1
SCHEMBL3193323 0.85 PDE4B (0.41) PDE4BGPR119
SCHEMBL3203826 0.85 PDE4B (0.39) PDE4BGPR119RXRA
SCHEMBL3255527 0.84 HRH4 (0.38) IMPDH2SLC7A5ALDH1A1IMPDH1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B AAK1 2805/4885PDE4B 2/4885GPR119 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.